Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and metformin for endometrial histology in disordered proliferative endometrium and simple endometrial hyperplasia
IRCT201412085563N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of letrozole and metformin in endometrial hyperplasia (EH) and disordered proliferative endometrium (DPE), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Effect on endometrial histology. Started Dec 2014; status: completed.
02
Drugs
letrozolemetformin
03
Conditions
endometrial hyperplasia (EH)disordered proliferative endometrium (DPE)
Beyond the preview
Go deeper on IRCT201412085563N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201412085563N6.